Phibro Animal Health Corporation reports developments in animal health, mineral nutrition and performance products for food-animal markets. The company develops, manufactures and markets antibacterials, anticoccidials, nutritional specialty products, vaccines and mineral nutrition products for poultry, swine, beef and dairy cattle, and aquaculture in the United States and international markets.
Recurring PAHC news includes quarterly results and guidance, cash dividend declarations on Class A and Class B common stock, investor conference participation and regulatory updates affecting antimicrobial products such as virginiamycin and bacitracin. Company updates also address product portfolio activity, acquisition-related effects, input and distribution costs, foreign-currency impacts and tools such as PhibroVet for veterinary prescription management.
Phibro Animal Health Corporation (NASDAQ: PAHC) is set to release its second-quarter financial results on February 3, 2021, post-market close. A conference call and webcast will follow on February 4, 2021, at 9:00 AM ET, allowing stakeholders to engage with management. Interested parties can access the presentation via their investor relations website. Phibro focuses on providing a diverse range of animal health and mineral nutrition products, supporting sustainable food production with fewer natural resources.
Phibro Animal Health Corporation (NASDAQ:PAHC) reported its Q1 2020 results with net sales of $195 million, a 3% increase year-over-year and net income rising to $12 million, up from $2.5 million. Diluted EPS reached $0.30, an increase of $0.24. The company noted strong performance in its core Animal Health segment, particularly in nutritional specialty products and vaccines, while Mineral Nutrition saw a decline. The outlook for Q2 forecasts net sales of about $205 million, reflecting ongoing recovery in the animal production industry.
Phibro Animal Health Corporation (NASDAQ:PAHC) will participate in the 29th Annual Credit Suisse Virtual Healthcare Conference on November 11, 2020, at 1:15 PM ET. Key executives, including Chairman and CEO Jack Bendheim, CFO Richard Johnson, and incoming CFO Damian Finio, will address financial analysts and investors. The presentation will be available live on the company’s Investor Relations Website, with a replay archived for later access. Phibro focuses on developing and supplying animal health and nutrition products to support healthy food production.
Phibro Animal Health Corporation (NASDAQ:PAHC) will release its first quarter financial results on November 4, 2020, after market close. A conference call and webcast are scheduled for November 5, 2020, at 9:00 AM ET.
Investors can participate in the call via phone or through a webcast available on the company's investor relations website. A replay will be accessible two hours after the live event. Phibro develops and supplies a wide range of animal health and nutrition products to support sustainable livestock production.